In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) was $1.17 for the day, down -8.95% from the previous closing price of $1.28. In other words, the price has decreased by -$8.95 from its previous closing price. On the day, 1.27 million shares were traded. ZNTL stock price reached its highest trading level at $1.28 during the session, while it also had its lowest trading level at $1.135.
Ratios:
Our analysis of ZNTL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.32 and its Current Ratio is at 7.32. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
On June 20, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $28 to $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 06 ’25 when Bruns Ingmar bought 20,000 shares for $2.28 per share. The transaction valued at 45,656 led to the insider holds 36,629 shares of the business.
Cam Gallagher bought 687 shares of ZNTL for $1,374 on Feb 11 ’25. On Feb 03 ’25, another insider, Vultaggio Vincent, who serves as the PAO and Interim PFO of the company, sold 2,615 shares for $1.71 each. As a result, the insider received 4,476 and left with 189,826 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 84019456 and an Enterprise Value of -244415536. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.25 while its Price-to-Book (P/B) ratio in mrq is 0.25. Its current Enterprise Value per Revenue stands at -3.625 whereas that against EBITDA is 1.313.
Stock Price History:
The Beta on a monthly basis for ZNTL is 1.83, which has changed by -0.91997266 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, ZNTL has reached a high of $16.21, while it has fallen to a 52-week low of $1.21. The 50-Day Moving Average of the stock is -39.81%, while the 200-Day Moving Average is calculated to be -61.78%.
Shares Statistics:
ZNTL traded an average of 1.75M shares per day over the past three months and 896680 shares per day over the past ten days. A total of 71.28M shares are outstanding, with a floating share count of 54.00M. Insiders hold about 24.81% of the company’s shares, while institutions hold 86.96% stake in the company. Shares short for ZNTL as of 1741910400 were 5326118 with a Short Ratio of 3.05, compared to 1739491200 on 5187320. Therefore, it implies a Short% of Shares Outstanding of 5326118 and a Short% of Float of 15.040000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
